Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Amil Gains as BTG Pactual Says Buy Brazil Healthcare

Amil Participacoes SA rose in Sao Paulo trading after Banco BTG Pactual SA recommended buying the shares, saying Brazil’s health-care industry will benefit from economic growth.

“We see growth opportunities across the sector,” Pactual analysts Joao Carlos dos Santos and Pedro Montenegro wrote in a note to clients on June 18. “Demographics are favorable thanks to population aging and wage bill growth.”

Health insurer Amil’s “stronger earnings power” and pharmaceutical-distributor Profarma Distribuidora de Produtos Farmaceuticos SA’s “too cheap” valuation earned the companies “buy” ratings in new coverage at the Rio de Janeiro-based bank.

Brazil’s economy will grow 7.06 percent this year, up from a week-earlier forecast of 6.99 percent, according to a central bank survey of about 100 economists published today. Analysts increased their prediction for economic growth for the 14th straight week.

Amil gained 1.4 percent to 14.70 reais, the highest price in almost two months. Profarma lost 0.1 percent to 15.25 reais after earlier increasing as much as 1.5 percent.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.